Acute Kidney Injury (Post-renal)

Post-renal AKI results from obstruction of urinary outflow at any level from the renal tubules to the urethral meatus. It accounts for approximately 2–5% of all AKI but is critically important because it is often reversible with timely intervention. [1-2] The potential for renal recovery is inversely related to the duration of obstruction. [3]

• Onset and urine output: Acute oliguria or anuria (complete anuria strongly suggests obstruction, bilateral cortical necrosis, or necrotizing GN). Alternating polyuria and oliguria/anuria is pathognomonic for intermittent obstruction. [4]
• Pain: Flank pain (unilateral or bilateral), suprapubic fullness, colicky pain radiating to groin (ureteral calculi)
• Lower urinary tract symptoms (LUTS): Hesitancy, weak stream, frequency, nocturia, incomplete emptying (suggests BPH or bladder outlet obstruction)
• Hematuria: Gross or microscopic — consider stones, malignancy, or clot retention
• Timing: Acute vs. subacute onset; recent surgery, instrumentation, or catheter changes
• Triggers: Recent anesthesia/anticholinergics (urinary retention), new medications (crystal nephropathy — acyclovir, methotrexate, sulfonamides) [3]
• Associated symptoms: Nausea/vomiting, weight loss (malignancy), constipation, back pain
• Important negatives: Absence of volume depletion symptoms (thirst, orthostasis), no nephrotoxin exposure, no rash/joint pain (rules against intrinsic renal causes)

• Anuria — until proven otherwise, assume complete bilateral obstruction or bladder outlet obstruction [4]
• Fever + obstruction = obstructed infected system (pyonephrosis/urosepsis) — a urologic emergency requiring emergent decompression [5-6]
• Hyperkalemia (K⁺ >6.0 mEq/L), severe metabolic acidosis, or uremic symptoms (encephalopathy, pericarditis, seizures)
• Rapidly rising creatinine with oliguria unresponsive to Foley catheter placement
• Bilateral hydronephrosis on imaging with worsening renal function
• Solitary kidney with any degree of obstruction [3][7]

• Contributors to obstruction:
  • Anticholinergics, opioids, sympathomimetics → urinary retention
  • Acyclovir, methotrexate, sulfonamides, indinavir → intratubular crystal obstruction [3]
  • Uricosuric agents → uric acid crystal deposition
• Medications to hold/adjust in AKI:
  • NSAIDs, ACE inhibitors/ARBs, aminoglycosides, metformin, lithium — hold or dose-adjust based on GFR [1]
  • Contrast agents — avoid iodinated contrast if possible [8]
• Treatment medications:
  • Tamsulosin 0.4 mg daily (if BPH-related retention)
  • Antibiotics if infected obstruction (ampicillin + gentamicin or fluoroquinolone, adjusted to culture) [5]
  • Calcium gluconate, insulin/dextrose, sodium bicarbonate, kayexalate for hyperkalemia management
• Contraindicated: Diuretics are not effective and should not be used to "treat" post-renal AKI; they do not relieve obstruction [9]

• Acute phase: Restrict potassium and phosphorus intake if hyperkalemia or hyperphosphatemia present
• Fluid management: Avoid aggressive IV fluids until obstruction is relieved (risk of worsening hydronephrosis/edema); post-obstructive diuresis may require significant fluid replacement
• Long-term (stone prevention): High fluid intake (>2.5 L/day), low sodium, adequate calcium, limited oxalate and animal protein depending on stone type
• Malignancy-related obstruction: Optimize nutritional status [1]

• GU: Dysuria, hematuria, urinary retention, incontinence, penile/vaginal discharge
• GI: Constipation (can worsen retention), abdominal distension, nausea/vomiting (uremia)
• Constitutional: Fever, chills (infection), weight loss, night sweats (malignancy)
• Neurologic: Confusion, asterixis, seizures (uremic encephalopathy)
• Cardiovascular: Dyspnea, orthopnea (volume overload), chest pain (uremic pericarditis)
• MSK: Back pain, bone pain (metastatic disease)

• Collateral: Baseline renal function (prior creatinine), prior imaging, medication list, recent procedures/surgeries, prior urologic history
• Family history: Nephrolithiasis, polycystic kidney disease, malignancy (prostate, cervical, colorectal, bladder)
• Social context: Occupational exposures, smoking history (bladder/renal cancer risk), substance use

• Male sex — BPH is the most common cause of lower tract obstruction; prostate cancer [3]
• Older age — prostatic hypertrophy, malignancy, neurogenic bladder [1][10]
• Known malignancy — cervical, prostate, colorectal, bladder, retroperitoneal lymphoma [3][11]
• Nephrolithiasis history — bilateral stones or stone in solitary kidney
• Neurogenic bladder — spinal cord injury, diabetes, MS, Parkinson's
• Retroperitoneal fibrosis — idiopathic or drug-induced (methysergide, ergotamines)
• Pregnancy — physiologic hydronephrosis vs. true obstruction
• Preexisting CKD — independently associated with AKI in obstructive uropathy and worse long-term outcomes [11]
• Solitary kidney — any unilateral obstruction causes AKI [7]

• Prerenal AKI — hypovolemia, heart failure, hepatorenal syndrome; distinguished by low FENa (<1%), response to volume resuscitation, no hydronephrosis [12]
• Intrinsic renal AKI — ATN, AIN, glomerulonephritis; muddy brown casts (ATN), WBC casts (AIN), RBC casts (GN); FENa typically >1% [12]
• Non-dilated obstructive uropathy (NDOU) — ~5% of obstructive cases present without hydronephrosis (retroperitoneal fibrosis, malignancy, severe dehydration); maintain high suspicion if anuria persists despite negative ultrasound [4][7]
• Acute urinary retention without AKI — large post-void residual but creatinine may be normal if unilateral or early
• Bilateral renal vein thrombosis — flank pain, hematuria, AKI; consider in nephrotic syndrome
• Abdominal compartment syndrome — critically ill patients; elevated bladder pressures [13]

• Prior nephrolithiasis episodes and stone composition
• BPH, prostate cancer, cervical/colorectal/bladder cancer
• Prior urologic surgery, stent placement, or nephrostomy
• Neurologic conditions affecting bladder function
• Chronic kidney disease (baseline creatinine is essential)
• Retroperitoneal fibrosis, radiation therapy
• Prior episodes of AKI

• Vitals: Fever (infected obstruction), hypertension (volume overload), tachycardia (sepsis/pain)
• Abdomen: Suprapubic distension/tenderness (bladder distension), flank tenderness (CVA tenderness), palpable kidneys (massive hydronephrosis, PCKD), abdominal masses
• DRE: Prostate size, nodularity, tenderness (BPH, prostate cancer, prostatitis)
• Pelvic exam (women): Cervical mass, pelvic mass, uterine enlargement
• Volume status: JVD, peripheral edema, pulmonary crackles (overload) vs. dry mucous membranes, poor skin turgor (dehydration — consider prerenal)
• Neurologic: Mental status changes, asterixis (uremia)
• Skin: Pallor, excoriations (uremic pruritus in advanced cases)

• BMP/CMP: Creatinine (elevated, rising), BUN (elevated, BUN:Cr ratio may be >20:1 early), potassium (hyperkalemia), bicarbonate (metabolic acidosis), calcium, phosphorus
• CBC: Leukocytosis (infection), anemia (chronic disease/malignancy)
• Urinalysis: May be bland; hematuria (stones, malignancy), pyuria/bacteriuria (infection), crystals
• Urine electrolytes/FENa: Early obstruction may show FENa <1% (mimics prerenal); prolonged obstruction → FENa >1% with tubular damage [12-13]
• Urine culture: If infection suspected
• PSA: If prostate pathology suspected (interpret cautiously in acute retention)
• Lactate: If sepsis/urosepsis suspected
• Blood gas: If severe acidosis suspected
• Post-obstructive monitoring: Serial creatinine, electrolytes, urine output (post-obstructive diuresis can cause significant electrolyte derangements)

• First-line: Renal/bladder ultrasound — the test of choice to detect hydronephrosis and assess bladder volume. The ACR Appropriateness Criteria recommend US kidneys/retroperitoneum as "usually appropriate" for initial AKI imaging. [8]
• POCUS: Sensitivity 87–93% and specificity 86–90% for hydronephrosis in moderate-to-high risk patients; NPV of 98% makes it excellent for ruling out obstruction at the bedside. [14-15]
• Non-contrast CT abdomen/pelvis: Gold standard for urolithiasis; useful to determine level and cause of obstruction when US shows hydronephrosis. Avoid IV contrast in AKI. [8]
• Important caveat: ~5% of obstructive uropathy presents without hydronephrosis (NDOU) — seen with retroperitoneal fibrosis, encasing malignancy, severe dehydration, or very early obstruction. If clinical suspicion remains high despite negative US, pursue CT or antegrade/retrograde pyelography. [4][7]
• When imaging is unnecessary: If a clear prerenal cause is identified and responds to volume resuscitation with no risk factors for obstruction

• Bladder scan/post-void residual (PVR): >200–300 mL suggests retention; immediate Foley catheter placement is both diagnostic and therapeutic for lower tract obstruction
• KDIGO staging: Stage AKI severity (Stage 1–3) based on creatinine rise and urine output [9]
• Antegrade or retrograde pyelography: Definitive test when non-invasive imaging is inconclusive; also therapeutic (stent placement)
• Renal scintigraphy (MAG3): Assess split renal function and drainage in subacute/chronic obstruction
• Cystoscopy: If bladder pathology or distal ureteral obstruction suspected

• Indications: Obtain in all patients with AKI and potassium >5.5 mEq/L or unknown potassium
• Hyperkalemia findings: Peaked T waves → widened QRS → sine wave pattern → cardiac arrest
• Uremic pericarditis: Diffuse ST elevation, PR depression (rare but critical)
• Bradycardia: May indicate severe hyperkalemia

Post-renal AKI is a reversible cause of renal failure when identified and treated promptly. The most common etiologies in adults are prostatic hypertrophy (most common overall), malignancy (prostate, cervical, colorectal, retroperitoneal), and nephrolithiasis. [3][11] AKI was present in 78% of patients with obstructive uropathy in one large multicenter study. [11] With early recognition and relief of obstruction, functional AKI can be rapidly reversed; however, prolonged obstruction leads to structural kidney injury with increased morbidity and mortality. [2][13]

Key complications to anticipate:

• Post-obstructive diuresis — can be massive (>200 mL/hr); risk of hypovolemia, hyponatremia, hypokalemia
• Urosepsis — infected obstructed system carries high mortality without emergent drainage
• Progression to CKD/ESKD — ESKD rate 4.4–6.8% in non-malignant obstruction; stage 3 AKI and preexisting CKD are independent predictors [11]

Initial stabilization

• ABCs; IV access; cardiac monitor if hyperkalemia suspected
• Treat life-threatening hyperkalemia immediately (calcium gluconate, insulin/dextrose, albuterol)
• Correct severe acidosis with sodium bicarbonate if pH <7.1

Relieve obstruction — the definitive treatment

• Lower tract obstruction (bladder outlet): Foley catheter insertion; if unable to pass, consult urology for suprapubic catheter [10]
• Upper tract obstruction: Percutaneous nephrostomy (

1. Acute Kidney Injury: Diagnosis and Management. — Mercado MG, Smith DK, Guard EL. American Family Physician. 2019.

2. Acute Kidney Injury: An Increasing Global Concern. — Lameire NH, Bagga A, Cruz D, et al. Lancet. 2013.

3. Acute Renal Failure. — Thadhani R, Pascual M, Bonventre JV. The New England Journal of Medicine. 1996.

4. Acute Oliguria. — Klahr S, Miller SB. The New England Journal of Medicine. 1998.

5. Acute Renal Colic from Ureteral Calculus. — Teichman JM. The New England Journal of Medicine. 2004.

6. CIRSE Standards of Practice on Nephrostomy and Ureteric Stent Placement and Exchange. — Ryan AG, Irvine I, Bardgett H, et al. Cardiovascular and Interventional Radiology. 2026.

7. Non-Dilated Obstructive Nephropathy. — Feliciangeli V, Noce A, Montalto G, et al. Clinical Kidney Journal. 2024.

8. ACR Appropriateness Criteria® Renal Failure. — Expert Panel on Urologic Imaging, Wong-You-Cheong JJ, Nikolaidis P, et al. Journal of the American College of Radiology : JACR. 2021.

9. Diuretics for Preventing and Treating Acute Kidney Injury. — Hashimoto H, Yamada H, Murata M, Watanabe N. The Cochrane Database of Systematic Reviews. 2025.

10. Acute Kidney Injury: A Guide to Diagnosis and Management. — Rahman M, Shad F, Smith MC. American Family Physician. 2012.

11. Impact of Acute Kidney Injury on Long-Term Adverse Outcomes in Obstructive Uropathy. — Yang J, Sun BG, Min HJ, et al. Scientific Reports. 2021.

12. Differential Diagnosis of Acute Renal Failure. — Espinel CH, Gregory AW. Clinical Nephrology. 1980.

13. Low-Flow Acute Kidney Injury: The Pathophysiology of Prerenal Azotemia, Abdominal Compartment Syndrome, and Obstructive Uropathy. — Molitoris BA. Clinical Journal of the American Society of Nephrology : CJASN. 2022.

14. Diagnostic Accuracy of Point-of-Care Ultrasonography for Obstructive Cause in Patients With Acute Kidney Injury: A Prospective Diagnosis Cohort. — Balen F, Drumare L, Laclergerie F, et al. Internal and Emergency Medicine. 2026.

15. Imaging of Medical Patients With Acute Kidney Injury: Patterns of Ultrasound Use and the Role of Point-of-Care Ultrasound at a Tertiary Care Center. — Gaudreau-Simard M, Ruller S, Dann M, et al. Journal of General Internal Medicine. 2025.